Tag: Policy + Advocacy Updates

In December, the Governor's Office of State Planning and Budgeting (OSPB), along with nonpartisan Legislative Council staff, presented strong budget forecasts which are a positive sign for the state’s...

Over the weekend Democratic Senator Joe Manchin of West Virginia announced that he would be voting ‘no’ on the Build Back Better Act (BBBA). His concerns with the legislation are primar...

Last month, President Biden announced Robert Califf, M.D. as his nominee for Commissioner of the Food and Drug Administration (FDA). Dr. Califf’s confirmation hearing was held this week by the Senate...

In addition to the ongoing conversations in the Senate related to the House of Representatives’ version of the $1.75 trillion Build Back Better Act (BBBA), the federal government will be seeking stric...

CBSA continues to monitor the international debate on the Trade-Relations Aspects of Intellectual Property Rights (TRIPS) Waiver. Our monitoring of the waiver is due the harmful precedent waving of IP...

World Antimicrobial Awareness Week, hosted by the World Health Organization last week, focused on increasing awareness of global antimicrobial resistance (AMR). and encou...

In addition to the price-setting policies and investment implications related to the capital gains tax rate and IRA provisions, the House version of the Build Back Better...

This week, CBSA was honored to host a dynamic briefing and roundtable discussion for Belgian Ambassador Jean-Arthur Régibeau. Our community appreciated the opportunity to...

Late last week, the White House released a framework for the budget reconciliation package, known as the Build Back Better Act. The original package had a total cost of $3.5 trillion. The latest frame...

The CBSA Board of Directors announced the appointment of Elyse Blazevich as our President & CEO on October 27. The Association is fortunate to have som...